- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Radiopharmaceutical market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Radiopharmaceuticalmarket, defines the market attractiveness level of Radiopharmaceutical market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Radiopharmaceutical industry, describes the types of Radiopharmaceutical market, the applications of major players and the market size, and deeply analyzes the current situation of the global Radiopharmaceutical market and the development prospects and opportunities of Radiopharmaceutical industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Radiopharmaceutical market in Chapter 13.
By Player:
Navidea
IBA Group
Bayer
Mallinckrodt
SIEMENS
GE Healthcare
Lantheus
Advanced Accelerator Applications
Triad Isotopes
Bracco Imaging
Jubilant Pharma
Nordion
Eli Lilly
Dongcheng
China Isotope & Radiation
By Type:
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
By End-User:
Oncology
Cardiology
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Radiopharmaceutical Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Radiopharmaceutical Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Radiopharmaceutical Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Radiopharmaceutical Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Radiopharmaceutical Market Analysis and Outlook to 2022
-
7.1 Global Radiopharmaceutical Consumption (2017-2022)
-
7.2 United States Radiopharmaceutical Consumption (2017-2022)
-
7.3 Europe Radiopharmaceutical Consumption (2017-2022)
-
7.4 China Radiopharmaceutical Consumption (2017-2022)
-
7.5 Japan Radiopharmaceutical Consumption (2017-2022)
-
7.6 India Radiopharmaceutical Consumption (2017-2022)
-
7.7 South Korea Radiopharmaceutical Consumption (2017-2022)
8 Region and Country-wise Radiopharmaceutical Market Analysis and Outlook to 2028
-
8.1 Global Radiopharmaceutical Consumption Forecast (2022-2028)
-
8.2 United States Radiopharmaceutical Consumption Forecast (2022-2028)
-
8.3 Europe Radiopharmaceutical Consumption Forecast (2022-2028)
-
8.4 China Radiopharmaceutical Consumption Forecast (2022-2028)
-
8.5 Japan Radiopharmaceutical Consumption Forecast (2022-2028)
-
8.6 India Radiopharmaceutical Consumption Forecast (2022-2028)
-
8.7 South Korea Radiopharmaceutical Consumption Forecast (2022-2028)
9 Global Radiopharmaceutical Market Outlook by Types and Applications to 2022
-
9.1 Global Radiopharmaceutical Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Actinium-225 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Lutetium-177 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Radium-223 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Holmium-166 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Radiopharmaceutical Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cardiology Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Radiopharmaceutical Market Outlook by Types and Applications to 2028
-
10.1 Global Radiopharmaceutical Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Actinium-225 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Lutetium-177 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Radium-223 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Holmium-166 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Radiopharmaceutical Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cardiology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Radiopharmaceutical Import and Export Analysis (Top 5 Countries)
-
11.1 Global Radiopharmaceutical Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Radiopharmaceutical Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Radiopharmaceutical Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Radiopharmaceutical Market Competitive Analysis
-
14.1 Navidea
-
14.1.1 Navidea Company Details
-
14.1.2 Navidea Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Navidea Radiopharmaceutical Product and Service
-
14.2 IBA Group
-
14.2.1 IBA Group Company Details
-
14.2.2 IBA Group Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 IBA Group Radiopharmaceutical Product and Service
-
14.3 Bayer
-
14.3.1 Bayer Company Details
-
14.3.2 Bayer Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bayer Radiopharmaceutical Product and Service
-
14.4 Mallinckrodt
-
14.4.1 Mallinckrodt Company Details
-
14.4.2 Mallinckrodt Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Mallinckrodt Radiopharmaceutical Product and Service
-
14.5 SIEMENS
-
14.5.1 SIEMENS Company Details
-
14.5.2 SIEMENS Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 SIEMENS Radiopharmaceutical Product and Service
-
14.6 GE Healthcare
-
14.6.1 GE Healthcare Company Details
-
14.6.2 GE Healthcare Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GE Healthcare Radiopharmaceutical Product and Service
-
14.7 Lantheus
-
14.7.1 Lantheus Company Details
-
14.7.2 Lantheus Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Lantheus Radiopharmaceutical Product and Service
-
14.8 Advanced Accelerator Applications
-
14.8.1 Advanced Accelerator Applications Company Details
-
14.8.2 Advanced Accelerator Applications Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Advanced Accelerator Applications Radiopharmaceutical Product and Service
-
14.9 Triad Isotopes
-
14.9.1 Triad Isotopes Company Details
-
14.9.2 Triad Isotopes Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Triad Isotopes Radiopharmaceutical Product and Service
-
14.10 Bracco Imaging
-
14.10.1 Bracco Imaging Company Details
-
14.10.2 Bracco Imaging Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bracco Imaging Radiopharmaceutical Product and Service
-
14.11 Jubilant Pharma
-
14.11.1 Jubilant Pharma Company Details
-
14.11.2 Jubilant Pharma Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Jubilant Pharma Radiopharmaceutical Product and Service
-
14.12 Nordion
-
14.12.1 Nordion Company Details
-
14.12.2 Nordion Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Nordion Radiopharmaceutical Product and Service
-
14.13 Eli Lilly
-
14.13.1 Eli Lilly Company Details
-
14.13.2 Eli Lilly Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Eli Lilly Radiopharmaceutical Product and Service
-
14.14 Dongcheng
-
14.14.1 Dongcheng Company Details
-
14.14.2 Dongcheng Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Dongcheng Radiopharmaceutical Product and Service
-
14.15 China Isotope & Radiation
-
14.15.1 China Isotope & Radiation Company Details
-
14.15.2 China Isotope & Radiation Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 China Isotope & Radiation Radiopharmaceutical Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Radiopharmaceutical
-
Figure Radiopharmaceutical Picture
-
Table Global Radiopharmaceutical Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Radiopharmaceutical Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Radiopharmaceutical Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Radiopharmaceutical Consumption by Country (2017-2022)
-
Figure United States Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Table Europe Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure China Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Japan Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure India Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure South Korea Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Global Radiopharmaceutical Consumption Forecast by Country (2022-2028)
-
Figure United States Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Actinium-225 Consumption and Growth Rate (2017-2022)
-
Figure Global Lutetium-177 Consumption and Growth Rate (2017-2022)
-
Figure Global Radium-223 Consumption and Growth Rate (2017-2022)
-
Figure Global Holmium-166 Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiology Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Actinium-225 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lutetium-177 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radium-223 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Holmium-166 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Radiopharmaceutical Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Radiopharmaceutical Export by Region (Top 5 Countries) (2017-2028)
-
Table Navidea (Foundation Year, Company Profile and etc.)
-
Table Navidea Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Navidea Radiopharmaceutical Product and Service
-
Table IBA Group (Foundation Year, Company Profile and etc.)
-
Table IBA Group Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table IBA Group Radiopharmaceutical Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Radiopharmaceutical Product and Service
-
Table Mallinckrodt (Foundation Year, Company Profile and etc.)
-
Table Mallinckrodt Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mallinckrodt Radiopharmaceutical Product and Service
-
Table SIEMENS (Foundation Year, Company Profile and etc.)
-
Table SIEMENS Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table SIEMENS Radiopharmaceutical Product and Service
-
Table GE Healthcare (Foundation Year, Company Profile and etc.)
-
Table GE Healthcare Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare Radiopharmaceutical Product and Service
-
Table Lantheus (Foundation Year, Company Profile and etc.)
-
Table Lantheus Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lantheus Radiopharmaceutical Product and Service
-
Table Advanced Accelerator Applications (Foundation Year, Company Profile and etc.)
-
Table Advanced Accelerator Applications Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Advanced Accelerator Applications Radiopharmaceutical Product and Service
-
Table Triad Isotopes (Foundation Year, Company Profile and etc.)
-
Table Triad Isotopes Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Triad Isotopes Radiopharmaceutical Product and Service
-
Table Bracco Imaging (Foundation Year, Company Profile and etc.)
-
Table Bracco Imaging Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bracco Imaging Radiopharmaceutical Product and Service
-
Table Jubilant Pharma (Foundation Year, Company Profile and etc.)
-
Table Jubilant Pharma Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jubilant Pharma Radiopharmaceutical Product and Service
-
Table Nordion (Foundation Year, Company Profile and etc.)
-
Table Nordion Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nordion Radiopharmaceutical Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Radiopharmaceutical Product and Service
-
Table Dongcheng (Foundation Year, Company Profile and etc.)
-
Table Dongcheng Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dongcheng Radiopharmaceutical Product and Service
-
Table China Isotope & Radiation (Foundation Year, Company Profile and etc.)
-
Table China Isotope & Radiation Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table China Isotope & Radiation Radiopharmaceutical Product and Service
-